BACKGROUND: @entity483 is a common paediatric dermatological condition. @entity11013 ( @entity11013 ) are central to treatment, but non-adherence leads to poor outcomes and treatment failure. Parents commonly cite @entity913 as an obstacle to treatment adherence. Dermatologists play a key role as clinician educators around the use, safety and efficacy of @entity11013 . OBJECTIVES: To assess dermatologists' attitudes towards and experiences of the use and safety of @entity11013 in managing @entity483 ( @entity483 ). METHODS: All 455 practicing Australasian College of Dermatologists fellows in Australia were surveyed either when attending the May 2014 annual scientific meeting or via two subsequent emails. The survey assessed their attitudes towards the use and safety of @entity11013 in treating @entity483 . RESULTS: Of 198 completed surveys, nearly all responders prescribed potent or super-potent @entity11013 to treat @entity483 . The most common @entity11013 side-effect cited by over two-thirds of respondents was peri-orificial @entity1909 . Most stated that pharmacists were the most common source of misinformation leading to @entity913 . Of the respondents, 75% strongly agreed that @entity11013 do not cause @entity272 when used appropriately and under clinical supervision. Furthermore, 77% agreed or strongly agreed that the words 'use sparingly' should be removed from pharmacist labels on @entity11013 prescriptions. CONCLUSIONS: Dermatologists manage @entity483 with potent or super-potent @entity11013 . Pharmacists are cited as the main contributor of misinformation leading to @entity913 , supporting the removal of the words 'use sparingly' from prescription @entity11013 . Most dermatologists believe @entity11013 do not cause @entity272 when used appropriately in @entity483 .

Attitudes of Australian dermatologists to the use and safety of topical corticosteroids in XXXX .

@entity483 :: ('MESH:D003876', 'Disease') :: ['paediatric atopic dermatitis', 'pAD', 'Atopic dermatitis'] @entity913 :: ('MESH:D010698', 'Disease') :: ['TCS phobia'] @entity272 :: ('MESH:D012871', 'Disease') :: ['skin atrophy'] @entity1909 :: ('MESH:D003872', 'Disease') :: ['dermatitis'] @entity11013 :: ('MESH:C565152', 'Disease') :: ['TCS', 'Topical corticosteroids']
@entity483 :: (MESH:D003876,Disease) :: ['paediatric atopic dermatitis']
